| Code |
Product Brand |
Composition |
Strength |
| DB001 |
HiGlan-2.5 |
| Each uncoated tablet contains: |
|
| Glibenclamide IP/BP |
2.5 mg |
|
| DB002 |
HiGlan-5 |
| Each uncoated tablet contains: |
|
| Glibenclamide IP/BP |
2.5 mg |
|
| DB004 |
Dibotab-2 |
| Each uncoated tablet contains: |
|
| Glimepiride IP |
2 mg |
|
| DB005 |
Dibotab-3 |
| Each uncoated tablet contains: |
|
| Glimepiride IP |
3 mg |
|
| DB007 |
Dimet-500 |
Each film coated sustained release
tablet contains: |
|
| Metformin Hydrochloride IP |
500 mg |
|
| DB008 |
Dimet-850 |
Each film coated sustained release
tablet contains: |
|
| Metformin Hydrochloride IP |
850 mg |
|
| DB009 |
Dimet-SR 850 |
Each film coated sustained release
tablet contains: |
|
| Metformin Hydrochloride IP |
850 mg |
|
| DB010 |
Dimet-SR 1000 |
Each film coated sustained release
tablet contains: |
|
| Metformin Hydrochloride IP |
1000 mg |
|
| DB011 |
Yogamet-GM 1 |
| Each uncoated bilayer tablet contains:: |
|
Metformin Hydrochloride IP
(as sustained release) |
500 mg |
| Glimepiride IP |
1 mg |
|
| DB012 |
Yogamet-GM 2 |
| Each uncoated bilayer tablet contains:: |
|
Metformin Hydrochloride IP
(as sustained release) |
500 mg |
| Glimepiride IP |
2 mg |
|
| DB013 |
Yogamet-GMP 1 |
| Each uncoated bilayer tablet contains:: |
|
Metformin Hydrochloride IP
(as sustained release) |
500 mg |
| Pioglitazone IP |
15 mg |
| Glimepiride IP |
1 mg |
|
| DB014 |
Yogamet-GMP 2 |
| Each uncoated bilayer tablet contains:: |
|
Metformin Hydrochloride IP
(as sustained release) |
500 mg |
| Pioglitazone IP |
15 mg |
| Glimepiride IP |
2 mg |
|
| DB015 |
Yogabos-0.2 |
| Each uncoated tablet contains:: |
|
Voglibose IP
| 0.2 mg |
|
| DB016 |
Yogabos-0.3 |
| Each uncoated tablet contains:: |
|
Voglibose IP
| 0.3 mg |
|
Go Back